Simplified scale for medication adherence related problems in HIV-infected;Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento antirretroviral

Farmacia Hospitalaria

Volumn 30, Issue 3, 2006, Pages 171-176

  Ventura Cerdá, José Manuel ^a   Minguez Gallego C ^a   Fernandez Villalba E M ^a   Alos Alminana M ^a   Andres Soler J ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Antiretroviral therapy; HIV; Outcome assessment; Patient compliance; Sensitivity; Specificity

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHARMACY; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY;

EID: 33747702245     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(06)73968-x     Document Type: Article

References (30)

1. Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 1999; 353: 863-8.
2. Gallant JE. Strategies for long-term success in the treatment of HIV infection. JAMA 2000; 283: 1329-34.
3. Escobar I, Knobel H, Polo R, Ortega L, Marín-Conde MT, Casado JL, et al. Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral en el año 2004. Farm Hosp 2004; 28(Supl. 1):6-18.
4. Le Moing V, Chêne G, Carrieri MP, Alioum A, Brun-Vézinet F, Piroth L, et al. Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS 2002; 16(1): 21-9.
5. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133 (1): 21-30.
6. Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA 2000; 283: 205-11.
7. Iribarren JA, Labarga P, Rubio R, Berenguer J, Miro JM, Antela A, et al. Recomendaciones de GESIDA/plan nacional del SIDA respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (Octubre 2004). Enferm Infecc Microbiol Clin 2004; 22: 564-642.
8. Cozzi Lepri A, Miller V, Phillips AN, Rabenau H, Sabin C, Staszewski S. The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load. AIDS 2001; 15: 47-54.
9. Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA study. AIDS 2002; 16: 605-13.
10. Altice FL, Friedland GH. The era of adherence to HIV therapy. Ann Intern Med 1998; 129: 503-5.
11. Murphy J, Coster G. Issues in patient compliance. Drugs 1997; 54: 797-800.
12. Turner BJ. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. JID 2002; 185 (Supl. 2): S143-51.
13. Codina C, Martínez M, Tuset M, del Cacho E, Martín MT, Miró JM, et al. Comparación de tres métodos de cálculo de adherencia en pacientes con tratamiento antirretroviral. Enferm Infecc Microbiol Clin 2002; 20: 484-90.
14. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health-Syst Pharm 2003; 60: 657-65.
15. Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Ann Pharmacother 2000; 34: 703-9.
16. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richamn DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000; 23: 386-95.
17. Duran S, Savès M, Spire B, Cailleton V, Sobel A, Carrieri P, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodistrophy. AIDS 2001; 15: 2441-4.
18. Tseng AL. Compliance issues in the treatment of HIV infection. Am J Health-Syst Pharm 1998; 55: 1817-24.
19. Murray MD, Birt JA, Manatunga AK, Darnell JC. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 1993; 27: 616-21.
20. Ena J, Pasquau F. Once-a-day highly active antiretroviral therapy: a systematic review. CID 2003; 36: 1186-90.
21. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002; 288: 2868-79.
22. Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998; 129: 573-8.
23. Gao X, Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother 2000; 34: 1117-22.
24. Bieszk N, Patel R, Heaberlin A, Wlasuk K, Zarowitz B. Detection of medication nonadherence through review of pharmacy claims data. Am J Health-Syst Pharm 2003; 60: 360-6.
25. Pérez-Simón MR, Cuevas MJ, Ortega L, Carro JA, Mostaza JL, Martín V, et al. Valoración de la adhesión al tratamiento antirretroviral: papel de la determinación de la concentración plasmática de los fármacos no análogos de nucleósidos. Med Clin (Barc) 2003; 120: 701-3.
26. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002; 16: 269-77.
27. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read 1999; 9: 329-38.
28. Carpentier CJ, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. Antiretroviral therapy in adults. Update recommendations of the international AIDS Society-USA Panel. JAMA 2000; 283: 381-90.
29. Escobar I, Campo M, Martín J, Fernández-Shaw C, Pulido F, Rubio R. Factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother 2003; 37: 775-81.
30. Stephenson J. AIDS researchers target poor adherence. JAMA 1999; 281: 1069.